Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shanna Pretzsch
Mp47-04 Refining Selection Criteria for Neoadjuvant Chemotherapy in Patients With Muscle Invasive Bladder Cancer: Combining Clinical Risk Features and Intrinsic Molecular Subtypes
Journal of Urology
Urology
Related publications
Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology
Cancer
Cancer Research
Oncology
Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Cancer
Cancer Research
Oncology
Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer
Urology
Urology
Magnetic Resonance Imaging Features of Breast Cancer According to Intrinsic Subtypes: Correlations With Neoadjuvant Chemotherapy Effects
SpringerPlus
Multidisciplinary
Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Pd15-09 Neoadjuvant vs Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Propensity Matched Analysis
Journal of Urology
Urology
Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
American Journal of Pathology
Forensic Medicine
Pathology
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer
Oncologist
Cancer Research
Medicine
Oncology
Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
